CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | Robb Gary Charles Chief Business Officer | Gift | +1,000 | 10,665 | ||
| 2025-03-10 | Swisher Daniel N JR Director | Option exercise 10b5-1 | +2,200 | $12.13 | $27K | 2,200 |
| 2025-03-10 | Swisher Daniel N JR Director | Sale 10b5-1 | −2,200 | $53.60 | $118K | 0 |
| 2025-03-10 | Swisher Daniel N JR Director | Option exercise · Stock option (right to buy) 10b5-1 | −2,200 | 4,000 | ||
| 2025-03-04 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +20,000 | $19.26 | $385K | 25,487 |
| 2025-03-04 | Guyer William Chief Development Officer | Sale 10b5-1 | −20,000 | $59.07 | $1.2M | 5,487 |
| 2025-03-04 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 30,000 | ||
| 2025-03-03 | Maduck Sean See Remarks | Shares withheld for taxes 10b5-1 | −228 | $60.58 | $14K | 85,090 |
| 2025-03-03 | Maduck Sean See Remarks | Grant or award 10b5-1 | +266 | $59.07 | $16K | 85,356 |
| 2025-03-03 | Maduck Sean See Remarks | Grant or award 10b5-1 | +266 | 85,622 | ||
| 2025-03-03 | Maduck Sean See Remarks | Option exercise 10b5-1 | +18,303 | $5.05 | $92K | 103,925 |
| 2025-03-03 | Maduck Sean See Remarks | Sale 10b5-1 | −18,303 | $60.69 | $1.1M | 85,622 |
| 2025-03-03 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −18,303 | 123,683 | ||
| 2025-03-03 | Lyon Joseph Douglas See Remarks | Shares withheld for taxes 10b5-1 | −182 | $60.58 | $11K | 8,577 |
| 2025-03-03 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +216 | $59.07 | $13K | 8,793 |
| 2025-03-03 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +216 | 9,009 | ||
| 2025-03-03 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +4,579 | $13.56 | $62K | 13,588 |
| 2025-03-03 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −4,579 | $60.69 | $278K | 9,009 |
| 2025-03-03 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −4,579 | 91,992 | ||
| 2025-03-03 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −2,924 | $60.91 | $178K | 3,019,411 |
Page 30 of 61 · 1,220 trades